Triomics’ $22M raise shows healthcare AI is going vertical

Healthcare AI is most compelling when it understands the details of a specific clinical workflow.

What happened

Triomics raised $22M to bring oncology-specific AI into cancer centres.

The company is focused on helping with cancer-care workflows rather than building a generic medical chatbot.

Why it matters

Oncology involves complex documentation, clinical context, and operational coordination. A vertical AI product may be more useful than a broad horizontal tool.

The bigger picture

The healthcare AI market is likely to fragment by specialty. The winners may be companies that go deep into specific clinical domains.